Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors.

Lockhart AC, Rothenberg ML, Dupont J, Cooper W, Chevalier P, Sternas L, Buzenet G, Koehler E, Sosman JA, Schwartz LH, Gultekin DH, Koutcher JA, Donnelly EF, Andal R, Dancy I, Spriggs DR, Tew WP
J Clin Oncol. 2010 28 (2): 207-14

PMID: 19949018 · PMCID: PMC2815710 · DOI:10.1200/JCO.2009.22.9237

MeSH Terms (14)

Adult Aged Angiogenesis Inhibitors Female Humans Infusions, Intravenous Male Maximum Tolerated Dose Middle Aged Neoplasms Protein Kinase Inhibitors Receptors, Vascular Endothelial Growth Factor Recombinant Fusion Proteins Vascular Endothelial Growth Factor A

Connections (2)

This publication is referenced by other Labnodes entities:

Links